J&J Unit Hit With $5.6M Verdict Over Calif. Risperdal Death
A California jury on Friday hit Johnson & Johnson unit Janssen Pharmaceuticals with a $5.6 million verdict for the wrongful death of a man during a clinical study of the company's...To view the full article, register now.
Already a subscriber? Click here to view full article